Futuretech Ii Acquisition CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
FutureTech II Acquisition Corp.'s 10-K filing outlines the company's share structure, warrant details, and ongoing efforts to complete a business combination, including a merger agreement with Longevity Biomedical Inc.
OTC.Pink
FutureTech II Acquisition Corp. has filed an amended annual report to correct errors related to extension loans and overpayments in share redemptions.
OTC.Pink
FutureTech II Acquisition Corp.'s 10-K filing outlines its capital structure, including Class A and Class B common stock, warrants, and key governance provisions.